APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Antibody Preparation Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Antibody Preparation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026197 pages

Choose your research edition.

Industry ResearchRecombinant Antibody Preparation Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Antibody Preparation Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Recombinant Antibody Preparation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Antibody Preparation Services Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Antibody Preparation Services Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Recombinant Antibody Preparation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Recombinant Antibody Preparation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Antibody Preparation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Antibody Preparation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Antibody Preparation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Antibody Preparation Services include Sino Biological, Evitria, Bio X Cell, Leinco Technologies, ProteoGenix, GENEWIZ, ProMab Biotechnologies, ProSci and RnDSystems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Recombinant Antibody Preparation Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Antibody Preparation Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Antibody Preparation Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Recombinant Antibody Preparation Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Antibody Preparation Services Segment by Company

Sino Biological

Evitria

Bio X Cell

Leinco Technologies

ProteoGenix

GENEWIZ

ProMab Biotechnologies

ProSci

RnDSystems

ProteoGenix

Rapid Novor

ACROBiosystems

Abveris

GTP Bioways

KMD Bioscience

Bioventix

Recombinant Antibody Preparation Services Segment by Type

Chimeric Antibodies

Humanized Antibodies

Fully Humanized Antibodies

Small Molecule Antibodies

Bispecific Antibodies

Recombinant Antibody Preparation Services Segment by Application

Drug Development

Clinical Research

Others

Recombinant Antibody Preparation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Antibody Preparation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Antibody Preparation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Antibody Preparation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Recombinant Antibody Preparation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Antibody Preparation Services industry.

Chapter 3: Detailed analysis of Recombinant Antibody Preparation Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Antibody Preparation Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Antibody Preparation Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chimeric Antibodies Table 3. Key Players of Humanized Antibodies Table 4. Key Players of Fully Humanized Antibodies Table 3. Key Players of Small Molecule Antibodies Table 4. Key Players of Bispecific Antibodies Table 5. Global Recombinant Antibody Preparation Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Drug Development Table 7. Key Players of Clinical Research Table 8. Key Players of Others Table 9. Global Recombinant Antibody Preparation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Recombinant Antibody Preparation Services Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Recombinant Antibody Preparation Services Market Share by Region (2021-2026) Table 12. Global Recombinant Antibody Preparation Services Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Recombinant Antibody Preparation Services Market Share by Region (2027-2032) Table 14. Recombinant Antibody Preparation Services Industry Trends Table 15. Recombinant Antibody Preparation Services Industry Drivers Table 16. Recombinant Antibody Preparation Services Industry Opportunities and Challenges Table 17. Recombinant Antibody Preparation Services Industry Restraints Table 18. Global Recombinant Antibody Preparation Services Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Recombinant Antibody Preparation Services Revenue Market Share by Company (2021-2026) Table 20. Global Recombinant Antibody Preparation Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Recombinant Antibody Preparation Services Key Company Head Office and Area Served Table 22. Global Recombinant Antibody Preparation Services Company, Product Type & Application Table 23. Global Recombinant Antibody Preparation Services Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Recombinant Antibody Preparation Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Recombinant Antibody Preparation Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Recombinant Antibody Preparation Services Revenue Market Share by Type (2021-2026) Table 30. Global Recombinant Antibody Preparation Services Revenue Market Share by Type (2027-2032) Table 31. Global Recombinant Antibody Preparation Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Recombinant Antibody Preparation Services Revenue Market Share by Application (2021-2026) Table 35. Global Recombinant Antibody Preparation Services Revenue Market Share by Application (2027-2032) Table 36. Sino Biological Company Information Table 37. Sino Biological Business Overview Table 38. Sino Biological Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sino Biological Recombinant Antibody Preparation Services Product Portfolio Table 40. Sino Biological Recent Development Table 41. Evitria Company Information Table 42. Evitria Business Overview Table 43. Evitria Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Evitria Recombinant Antibody Preparation Services Product Portfolio Table 45. Evitria Recent Development Table 46. Bio X Cell Company Information Table 47. Bio X Cell Business Overview Table 48. Bio X Cell Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bio X Cell Recombinant Antibody Preparation Services Product Portfolio Table 50. Bio X Cell Recent Development Table 51. Leinco Technologies Company Information Table 52. Leinco Technologies Business Overview Table 53. Leinco Technologies Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Leinco Technologies Recombinant Antibody Preparation Services Product Portfolio Table 55. Leinco Technologies Recent Development Table 56. ProteoGenix Company Information Table 57. ProteoGenix Business Overview Table 58. ProteoGenix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ProteoGenix Recombinant Antibody Preparation Services Product Portfolio Table 60. ProteoGenix Recent Development Table 61. GENEWIZ Company Information Table 62. GENEWIZ Business Overview Table 63. GENEWIZ Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. GENEWIZ Recombinant Antibody Preparation Services Product Portfolio Table 65. GENEWIZ Recent Development Table 66. ProMab Biotechnologies Company Information Table 67. ProMab Biotechnologies Business Overview Table 68. ProMab Biotechnologies Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ProMab Biotechnologies Recombinant Antibody Preparation Services Product Portfolio Table 70. ProMab Biotechnologies Recent Development Table 71. ProSci Company Information Table 72. ProSci Business Overview Table 73. ProSci Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ProSci Recombinant Antibody Preparation Services Product Portfolio Table 75. ProSci Recent Development Table 76. RnDSystems Company Information Table 77. RnDSystems Business Overview Table 78. RnDSystems Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. RnDSystems Recombinant Antibody Preparation Services Product Portfolio Table 80. RnDSystems Recent Development Table 81. ProteoGenix Company Information Table 82. ProteoGenix Business Overview Table 83. ProteoGenix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. ProteoGenix Recombinant Antibody Preparation Services Product Portfolio Table 85. ProteoGenix Recent Development Table 86. Rapid Novor Company Information Table 87. Rapid Novor Business Overview Table 88. Rapid Novor Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Rapid Novor Recombinant Antibody Preparation Services Product Portfolio Table 90. Rapid Novor Recent Development Table 91. ACROBiosystems Company Information Table 92. ACROBiosystems Business Overview Table 93. ACROBiosystems Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. ACROBiosystems Recombinant Antibody Preparation Services Product Portfolio Table 95. ACROBiosystems Recent Development Table 96. Abveris Company Information Table 97. Abveris Business Overview Table 98. Abveris Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Abveris Recombinant Antibody Preparation Services Product Portfolio Table 100. Abveris Recent Development Table 101. GTP Bioways Company Information Table 102. GTP Bioways Business Overview Table 103. GTP Bioways Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. GTP Bioways Recombinant Antibody Preparation Services Product Portfolio Table 105. GTP Bioways Recent Development Table 106. KMD Bioscience Company Information Table 107. KMD Bioscience Business Overview Table 108. KMD Bioscience Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. KMD Bioscience Recombinant Antibody Preparation Services Product Portfolio Table 110. KMD Bioscience Recent Development Table 111. Bioventix Company Information Table 112. Bioventix Business Overview Table 113. Bioventix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Bioventix Recombinant Antibody Preparation Services Product Portfolio Table 115. Bioventix Recent Development Table 116. North America Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 117. North America Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 118. North America Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 119. North America Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 120. North America Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Recombinant Antibody Preparation Services Market Size by Country (2021-2026) Table 122. North America Recombinant Antibody Preparation Services Market Size by Country (2027-2032) Table 123. Europe Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 124. Europe Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 125. Europe Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 126. Europe Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 127. Europe Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Recombinant Antibody Preparation Services Market Size by Country (2021-2026) Table 129. Europe Recombinant Antibody Preparation Services Market Size by Country (2027-2032) Table 130. China Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 131. China Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 132. China Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 133. China Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 134. Asia Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 135. Asia Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 136. Asia Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 137. Asia Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Recombinant Antibody Preparation Services Market Size by Country (2021-2026) Table 140. Asia Recombinant Antibody Preparation Services Market Size by Country (2027-2032) Table 141. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Type (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Type (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Application (2021-2026) & (US$ Million) Table 144. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Application (2027-2032) & (US$ Million) Table 145. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2021-2026) Table 147. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Recombinant Antibody Preparation Services Product Image Figure 2. Global Recombinant Antibody Preparation Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Recombinant Antibody Preparation Services Market Share by Type: 2025 VS 2032 Figure 4. Chimeric Antibodies Image Figure 5. Humanized Antibodies Image Figure 6. Fully Humanized Antibodies Image Figure 7. Small Molecule Antibodies Image Figure 8. Bispecific Antibodies Image Figure 9. Global Recombinant Antibody Preparation Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Recombinant Antibody Preparation Services Market Share by Application: 2025 VS 2032 Figure 11. Drug Development Image Figure 12. Clinical Research Image Figure 13. Others Image Figure 14. Global Recombinant Antibody Preparation Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 16. Global Recombinant Antibody Preparation Services Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Recombinant Antibody Preparation Services Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Recombinant Antibody Preparation Services Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Recombinant Antibody Preparation Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Recombinant Antibody Preparation Services Revenue Market Share by Type (2021-2032) Figure 23. Global Recombinant Antibody Preparation Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Recombinant Antibody Preparation Services Revenue Market Share by Application (2021-2032) Figure 25. North America Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 26. North America Recombinant Antibody Preparation Services Market Share by Type (2021-2032) Figure 27. North America Recombinant Antibody Preparation Services Market Share by Application (2021-2032) Figure 28. North America Recombinant Antibody Preparation Services Market Share by Country (2021-2032) Figure 29. United States Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 30. Canada Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 33. Europe Recombinant Antibody Preparation Services Market Share by Type (2021-2032) Figure 34. Europe Recombinant Antibody Preparation Services Market Share by Application (2021-2032) Figure 35. Europe Recombinant Antibody Preparation Services Market Share by Country (2021-2032) Figure 36. Germany Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 37. France Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 39. Italy Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 40. Russia Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 42. China Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 43. China Recombinant Antibody Preparation Services Market Share by Type (2021-2032) Figure 44. China Recombinant Antibody Preparation Services Market Share by Application (2021-2032) Figure 45. Asia Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 46. Asia Recombinant Antibody Preparation Services Market Share by Type (2021-2032) Figure 47. Asia Recombinant Antibody Preparation Services Market Share by Application (2021-2032) Figure 48. Asia Recombinant Antibody Preparation Services Market Share by Country (2021-2032) Figure 49. Japan Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 53. India Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 54. Australia Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Country (2021-2032) Figure 59. Brazil Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 64. UAE Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 66. Chile Recombinant Antibody Preparation Services Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Chimeric Antibodies
  • Humanized Antibodies
  • Fully Humanized Antibodies
  • Small Molecule Antibodies
  • Bispecific Antibodies
Applications
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • Sino Biological
  • Evitria
  • Bio X Cell
  • Leinco Technologies
  • ProteoGenix
  • GENEWIZ
  • ProMab Biotechnologies
  • ProSci
  • RnDSystems
  • ProteoGenix
  • Rapid Novor
  • ACROBiosystems
  • Abveris
  • GTP Bioways
  • KMD Bioscience
  • Bioventix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Recombinant Antibody Preparation Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chimeric Antibodies
  5. 1.2.3 Humanized Antibodies
  6. 1.2.4 Fully Humanized Antibodies
  7. 1.2.5 Small Molecule Antibodies
  8. 1.2.6 Bispecific Antibodies
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Recombinant Antibody Preparation Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Drug Development
  12. 1.3.3 Clinical Research
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Recombinant Antibody Preparation Services Growth Trends by Region
  16. 1.5.1 Global Recombinant Antibody Preparation Services Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Recombinant Antibody Preparation Services Market Size by Region (2021-2026)
  18. 1.5.3 Recombinant Antibody Preparation Services Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Recombinant Antibody Preparation Services Market Dynamics
  1. 2.1 Recombinant Antibody Preparation Services Industry Trends
  2. 2.2 Recombinant Antibody Preparation Services Industry Drivers
  3. 2.3 Recombinant Antibody Preparation Services Industry Opportunities and Challenges
  4. 2.4 Recombinant Antibody Preparation Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Recombinant Antibody Preparation Services Revenue by Company (2021-2026)
  2. 3.2 Global Recombinant Antibody Preparation Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Recombinant Antibody Preparation Services Key Company Head office and Area Served
  4. 3.4 Global Recombinant Antibody Preparation Services Company, Product Type & Application
  5. 3.5 Global Recombinant Antibody Preparation Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Recombinant Antibody Preparation Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Recombinant Antibody Preparation Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Recombinant Antibody Preparation Services Tier 1, Tier 2, and Tier 3
4 Recombinant Antibody Preparation Services Market by Type
  1. 4.1 Global Recombinant Antibody Preparation Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Recombinant Antibody Preparation Services Market Size by Type (2021-2032)
  3. 4.3 Global Recombinant Antibody Preparation Services Market Size Share by Type (2021-2032)
5 Recombinant Antibody Preparation Services Market by Application
  1. 5.1 Global Recombinant Antibody Preparation Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Recombinant Antibody Preparation Services Market Size by Application (2021-2032)
  3. 5.3 Global Recombinant Antibody Preparation Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sino Biological
  2. 6.1.1 Sino Biological Company Information
  3. 6.1.2 Sino Biological Business Overview
  4. 6.1.3 Sino Biological Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sino Biological Recombinant Antibody Preparation Services Product Portfolio
  6. 6.1.5 Sino Biological Recent Developments
  7. 6.2 Evitria
  8. 6.2.1 Evitria Company Information
  9. 6.2.2 Evitria Business Overview
  10. 6.2.3 Evitria Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Evitria Recombinant Antibody Preparation Services Product Portfolio
  12. 6.2.5 Evitria Recent Developments
  13. 6.3 Bio X Cell
  14. 6.3.1 Bio X Cell Company Information
  15. 6.3.2 Bio X Cell Business Overview
  16. 6.3.3 Bio X Cell Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bio X Cell Recombinant Antibody Preparation Services Product Portfolio
  18. 6.3.5 Bio X Cell Recent Developments
  19. 6.4 Leinco Technologies
  20. 6.4.1 Leinco Technologies Company Information
  21. 6.4.2 Leinco Technologies Business Overview
  22. 6.4.3 Leinco Technologies Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Leinco Technologies Recombinant Antibody Preparation Services Product Portfolio
  24. 6.4.5 Leinco Technologies Recent Developments
  25. 6.5 ProteoGenix
  26. 6.5.1 ProteoGenix Company Information
  27. 6.5.2 ProteoGenix Business Overview
  28. 6.5.3 ProteoGenix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ProteoGenix Recombinant Antibody Preparation Services Product Portfolio
  30. 6.5.5 ProteoGenix Recent Developments
  31. 6.6 GENEWIZ
  32. 6.6.1 GENEWIZ Company Information
  33. 6.6.2 GENEWIZ Business Overview
  34. 6.6.3 GENEWIZ Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GENEWIZ Recombinant Antibody Preparation Services Product Portfolio
  36. 6.6.5 GENEWIZ Recent Developments
  37. 6.7 ProMab Biotechnologies
  38. 6.7.1 ProMab Biotechnologies Company Information
  39. 6.7.2 ProMab Biotechnologies Business Overview
  40. 6.7.3 ProMab Biotechnologies Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ProMab Biotechnologies Recombinant Antibody Preparation Services Product Portfolio
  42. 6.7.5 ProMab Biotechnologies Recent Developments
  43. 6.8 ProSci
  44. 6.8.1 ProSci Company Information
  45. 6.8.2 ProSci Business Overview
  46. 6.8.3 ProSci Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ProSci Recombinant Antibody Preparation Services Product Portfolio
  48. 6.8.5 ProSci Recent Developments
  49. 6.9 RnDSystems
  50. 6.9.1 RnDSystems Company Information
  51. 6.9.2 RnDSystems Business Overview
  52. 6.9.3 RnDSystems Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 RnDSystems Recombinant Antibody Preparation Services Product Portfolio
  54. 6.9.5 RnDSystems Recent Developments
  55. 6.10 ProteoGenix
  56. 6.10.1 ProteoGenix Company Information
  57. 6.10.2 ProteoGenix Business Overview
  58. 6.10.3 ProteoGenix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ProteoGenix Recombinant Antibody Preparation Services Product Portfolio
  60. 6.10.5 ProteoGenix Recent Developments
  61. 6.11 Rapid Novor
  62. 6.11.1 Rapid Novor Company Information
  63. 6.11.2 Rapid Novor Business Overview
  64. 6.11.3 Rapid Novor Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Rapid Novor Recombinant Antibody Preparation Services Product Portfolio
  66. 6.11.5 Rapid Novor Recent Developments
  67. 6.12 ACROBiosystems
  68. 6.12.1 ACROBiosystems Company Information
  69. 6.12.2 ACROBiosystems Business Overview
  70. 6.12.3 ACROBiosystems Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 ACROBiosystems Recombinant Antibody Preparation Services Product Portfolio
  72. 6.12.5 ACROBiosystems Recent Developments
  73. 6.13 Abveris
  74. 6.13.1 Abveris Company Information
  75. 6.13.2 Abveris Business Overview
  76. 6.13.3 Abveris Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Abveris Recombinant Antibody Preparation Services Product Portfolio
  78. 6.13.5 Abveris Recent Developments
  79. 6.14 GTP Bioways
  80. 6.14.1 GTP Bioways Company Information
  81. 6.14.2 GTP Bioways Business Overview
  82. 6.14.3 GTP Bioways Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GTP Bioways Recombinant Antibody Preparation Services Product Portfolio
  84. 6.14.5 GTP Bioways Recent Developments
  85. 6.15 KMD Bioscience
  86. 6.15.1 KMD Bioscience Company Information
  87. 6.15.2 KMD Bioscience Business Overview
  88. 6.15.3 KMD Bioscience Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 KMD Bioscience Recombinant Antibody Preparation Services Product Portfolio
  90. 6.15.5 KMD Bioscience Recent Developments
  91. 6.16 Bioventix
  92. 6.16.1 Bioventix Company Information
  93. 6.16.2 Bioventix Business Overview
  94. 6.16.3 Bioventix Recombinant Antibody Preparation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Bioventix Recombinant Antibody Preparation Services Product Portfolio
  96. 6.16.5 Bioventix Recent Developments
7 North America
  1. 7.1 North America Recombinant Antibody Preparation Services Market Size (2021-2032)
  2. 7.2 North America Recombinant Antibody Preparation Services Market Size by Type
  3. 7.2.1 North America Recombinant Antibody Preparation Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Recombinant Antibody Preparation Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Recombinant Antibody Preparation Services Market Share by Type (2021-2032)
  6. 7.3 North America Recombinant Antibody Preparation Services Market Size by Application
  7. 7.3.1 North America Recombinant Antibody Preparation Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Recombinant Antibody Preparation Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Recombinant Antibody Preparation Services Market Share by Application (2021-2032)
  10. 7.4 North America Recombinant Antibody Preparation Services Market Size by Country
  11. 7.4.1 North America Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Recombinant Antibody Preparation Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Recombinant Antibody Preparation Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Recombinant Antibody Preparation Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Recombinant Antibody Preparation Services Market Size (2021-2032)
  2. 8.2 Europe Recombinant Antibody Preparation Services Market Size by Type
  3. 8.2.1 Europe Recombinant Antibody Preparation Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Recombinant Antibody Preparation Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Recombinant Antibody Preparation Services Market Share by Type (2021-2032)
  6. 8.3 Europe Recombinant Antibody Preparation Services Market Size by Application
  7. 8.3.1 Europe Recombinant Antibody Preparation Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Recombinant Antibody Preparation Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Recombinant Antibody Preparation Services Market Share by Application (2021-2032)
  10. 8.4 Europe Recombinant Antibody Preparation Services Market Size by Country
  11. 8.4.1 Europe Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Recombinant Antibody Preparation Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Recombinant Antibody Preparation Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Recombinant Antibody Preparation Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Recombinant Antibody Preparation Services Market Size (2021-2032)
  2. 9.2 China Recombinant Antibody Preparation Services Market Size by Type
  3. 9.2.1 China Recombinant Antibody Preparation Services Market Size by Type (2021-2026)
  4. 9.2.2 China Recombinant Antibody Preparation Services Market Size by Type (2027-2032)
  5. 9.2.3 China Recombinant Antibody Preparation Services Market Share by Type (2021-2032)
  6. 9.3 China Recombinant Antibody Preparation Services Market Size by Application
  7. 9.3.1 China Recombinant Antibody Preparation Services Market Size by Application (2021-2026)
  8. 9.3.2 China Recombinant Antibody Preparation Services Market Size by Application (2027-2032)
  9. 9.3.3 China Recombinant Antibody Preparation Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Recombinant Antibody Preparation Services Market Size (2021-2032)
  2. 10.2 Asia Recombinant Antibody Preparation Services Market Size by Type
  3. 10.2.1 Asia Recombinant Antibody Preparation Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Recombinant Antibody Preparation Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Recombinant Antibody Preparation Services Market Share by Type (2021-2032)
  6. 10.3 Asia Recombinant Antibody Preparation Services Market Size by Application
  7. 10.3.1 Asia Recombinant Antibody Preparation Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Recombinant Antibody Preparation Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Recombinant Antibody Preparation Services Market Share by Application (2021-2032)
  10. 10.4 Asia Recombinant Antibody Preparation Services Market Size by Country
  11. 10.4.1 Asia Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Recombinant Antibody Preparation Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Recombinant Antibody Preparation Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Recombinant Antibody Preparation Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Recombinant Antibody Preparation Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst